April 24, 2020 / 2:00 PM / a month ago

BRIEF-FDA Cautions Against Use Of Hydroxychloroquine Or Chloroquine For Covid-19 Outside Of Hospital Setting Due To Risk Of Heart Rhythm Problems

April 24 (Reuters) - U.S. FDA:

* FDA CAUTIONS AGAINST USE OF HYDROXYCHLOROQUINE OR CHLOROQUINE FOR COVID-19 OUTSIDE OF HOSPITAL SETTING OR CLINICAL TRIAL DUE TO RISK OF HEART RHYTHM PROBLEMS

* FDA - AWARE OF REPORTS OF SERIOUS HEART RHYTHM PROBLEMS IN PATIENTS WITH COVID-19 TREATED WITH HYDROXYCHLOROQUINE OR CHLOROQUINE

* FDA- TO CONTINUE TO INVESTIGATE RISKS RELATED TO USE OF HYDROXYCHLOROQUINE, CHLOROQUINE FOR COVID-19, COMMUNICATE PUBLICLY WHEN HAVE MORE INFORMATION

* FDA SAYS HYDROXYCHLOROQUINE & CHLOROQUINE HAVE NOT BEEN SHOWN TO BE SAFE & EFFECTIVE FOR TREATING OR PREVENTING COVID-19

* FDA SAYS SERIOUS POISONING AND DEATH HAVE BEEN REPORTED AFTER MISTAKEN USE OF A CHLOROQUINE PRODUCT NOT INTENDED TO BE TAKEN BY HUMANS

* FDA - RECOMMEND INITIAL EVALUATION, MONITORING WHEN USING HYDROXYCHLOROQUINE, CHLOROQUINE UNDER EUA, CLINICAL TRIALS INVESTIGATING COVID-19 MEDICINES Source text: (bit.ly/352Brtn)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below